SMSLIFE — SMS Lifesciences India Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual income statement for SMS Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,656	3,497	3,156	3,060	3,447
Cost of Revenue
Gross Profit	837	976	946	1,024	1,251
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	2,433	3,256	2,976	2,898	3,147
Operating Profit	223	242	180	162	300
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	196	327	166	98.5	262
Provision for Income Taxes
Net Income After Taxes	136	253	114	63.3	187
Minority Interest
Net Income Before Extraordinary Items
Net Income	136	253	115	90.9	201
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	136	253	115	90.9	201
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	44.8	63.5	32.6	30.1	66.5
Dividends per Share